Average Co-Inventor Count = 3.00
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Actelion Pharmaceuticals Ltd (3 from 217 patents)
2. Idorsia Pharmaceuticals Ltd (3 from 77 patents)
3. Vanda Pharmaceuticals Inc. (1 from 108 patents)
4. Novartis Ag (3,923 patents)
5. Novartis Pharma Gmbh (8 patents)
7 patents:
1. 12336980 - Dosing regimen for a selective S1P1 receptor agonist
2. 11834443 - Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
3. 11771683 - Dosing regimen for a selective S1Preceptor agonist
4. 11390615 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox
5. 10857134 - Dosing regimen for a selective S1Preceptor agonist
6. 10836754 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
7. 10220023 - [object Object]